DE3220932C2 - - Google Patents
Info
- Publication number
- DE3220932C2 DE3220932C2 DE19823220932 DE3220932A DE3220932C2 DE 3220932 C2 DE3220932 C2 DE 3220932C2 DE 19823220932 DE19823220932 DE 19823220932 DE 3220932 A DE3220932 A DE 3220932A DE 3220932 C2 DE3220932 C2 DE 3220932C2
- Authority
- DE
- Germany
- Prior art keywords
- cyanoacrylate
- bone
- composition
- ethyl
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 78
- 210000000988 bone and bone Anatomy 0.000 claims description 57
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- 159000000007 calcium salts Chemical class 0.000 claims description 11
- IQDPHMACOQAPBQ-UHFFFAOYSA-N 2-ethoxyethyl 2-cyanoprop-2-enoate Chemical compound CCOCCOC(=O)C(=C)C#N IQDPHMACOQAPBQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000004227 calcium gluconate Substances 0.000 claims description 9
- 229960004494 calcium gluconate Drugs 0.000 claims description 9
- 235000013927 calcium gluconate Nutrition 0.000 claims description 9
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 9
- 230000008929 regeneration Effects 0.000 claims description 9
- 238000011069 regeneration method Methods 0.000 claims description 9
- 239000000945 filler Substances 0.000 claims description 8
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 22
- 238000009472 formulation Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000006065 biodegradation reaction Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 229940064004 antiseptic throat preparations Drugs 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000316 bone substitute Substances 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- DRSFTXMPYWKJDK-UHFFFAOYSA-N N1=C(C=C1)OCC1=NC2=CC=CC=C2N=C1 Chemical compound N1=C(C=C1)OCC1=NC2=CC=CC=C2N=C1 DRSFTXMPYWKJDK-UHFFFAOYSA-N 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000001180 ethmoid sinus Anatomy 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 210000004086 maxillary sinus Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000022949 middle ear disease Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- -1 poly ethylene Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- PZLGAOXMPNXQBW-UHFFFAOYSA-N quinoxalin-2-ylmethanol Chemical compound C1=CC=CC2=NC(CO)=CN=C21 PZLGAOXMPNXQBW-UHFFFAOYSA-N 0.000 description 1
- 238000011470 radical surgery Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
- A61L24/0089—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823220932 DE3220932A1 (de) | 1982-06-03 | 1982-06-03 | Zusammensetzung zur zeitweiligen knochengewebssubstitution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823220932 DE3220932A1 (de) | 1982-06-03 | 1982-06-03 | Zusammensetzung zur zeitweiligen knochengewebssubstitution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3220932A1 DE3220932A1 (de) | 1983-12-08 |
| DE3220932C2 true DE3220932C2 (enrdf_load_stackoverflow) | 1989-04-06 |
Family
ID=6165222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19823220932 Granted DE3220932A1 (de) | 1982-06-03 | 1982-06-03 | Zusammensetzung zur zeitweiligen knochengewebssubstitution |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE3220932A1 (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19843254A1 (de) * | 1998-09-10 | 2000-03-23 | Schering Ag | Verwendung von Polymermischungen, die Cyanacrylat oder Methylenmalonester enthalten, zur Beschichtung medizinischer Geräte und Implantate |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10212348A1 (de) * | 2002-03-14 | 2003-09-25 | Aesculap Ag & Co Kg | Aushärtbare Zusammensetzung, Verfahren zu ihrer Herstellung und Verwendung in der Knochenchirurgie |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3759264A (en) * | 1966-04-07 | 1973-09-18 | Eastman Kodak Co | Surgical method |
| GB1164356A (en) * | 1966-10-10 | 1969-09-17 | Fred Leonard | alpha-Cyanoacrylic Acid Ester Pastes. |
| US3559652A (en) * | 1968-08-05 | 1971-02-02 | Minnesota Mining & Mfg | Method of adhesively repairing body tissue with alkoxyalkyl 2-cyanoacrylate |
| GB1413132A (en) * | 1972-10-20 | 1975-11-05 | Vni I Ispygatelny I Med Tekhn | Surgical adhesive |
| DE2501683C3 (de) * | 1975-01-17 | 1979-11-29 | Ernst Leitz Wetzlar Gmbh, 6300 Wetzlar | Polymeres Verbundmaterial für prothetische Zwecke und Verfahren zu seiner Herstellung |
| GB1560992A (en) * | 1976-07-06 | 1980-02-13 | Univ Virginia | Osseous cement |
| GB1548419A (en) * | 1976-08-12 | 1979-07-11 | British Petroleum Co | Fabrication of polymer cements |
| US4200939A (en) * | 1977-10-19 | 1980-05-06 | Codman & Shurtleff, Inc. | Method for fixation of prostheses to bone |
-
1982
- 1982-06-03 DE DE19823220932 patent/DE3220932A1/de active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19843254A1 (de) * | 1998-09-10 | 2000-03-23 | Schering Ag | Verwendung von Polymermischungen, die Cyanacrylat oder Methylenmalonester enthalten, zur Beschichtung medizinischer Geräte und Implantate |
| DE19843254C2 (de) * | 1998-09-10 | 2000-07-06 | Schering Ag | Verwendung von Polymermischungen, die Cyanacrylat oder Methylenmalonester enthalten, zur Beschichtung medizinischer Geräte und Implantate, medizinische Implantate und Verfahren zu ihrer Herstellung |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3220932A1 (de) | 1983-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0016906B1 (de) | Knochenzement und Verfahren zu seiner Herstellung | |
| DE602005000957T2 (de) | Polymerer Zement für die perkutane Vertebroplastie | |
| DE60305036T2 (de) | Hydraulischer zement auf basis von calciumphosphat für chirurgische anwendungen | |
| EP1227851B1 (de) | Resorbierbares knochen-implantatmaterial sowie verfahren zur herstellung desselben | |
| EP1121161B1 (de) | Zusammensetzung zur implantation in den menschlichen und tierischen körper | |
| DE69715824T2 (de) | Verfahren zur herstellung eines implantierbaren verbundwerkstoffs, so hergestellte werkstoffe, und kit zur durchführung des verfahrens | |
| AT401229B (de) | Zwei-phasen-knochenzement | |
| DE60116098T2 (de) | Zusammensetzung für einen injizierbaren knochenmineral ersatz | |
| EP0950420A2 (de) | Tricalciumphosphathaltige Biozementpasten mit Kohäsionspromotoren | |
| DE68910923T2 (de) | Knochenzement. | |
| DE69011807T2 (de) | Knochenzement, daraus hergestellter gehärteter Gegenstand, Implantationsmaterial und Verfahren zu seiner Präparation. | |
| DE69636989T2 (de) | Bioaktive lasttragende zusammensetzungen zum knochenverbund | |
| DE69331096T2 (de) | Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung | |
| DE68912302T2 (de) | Härtendes material für medizinischen und dentalen gebrauch. | |
| CH634228A5 (de) | Verfahren zur herstellung eines neuen antibiotikahaltigen mittels aus kunststoffpartikeln. | |
| EP0229771B1 (de) | Knochenzement | |
| DE10355992A1 (de) | Bioresorbierbares Kompositmaterial | |
| US4407793A (en) | Composition for temporary substitution of bone tissue defects | |
| DE19853832A1 (de) | Polyalkensäuren enthaltende Calcium-Phosphatzemente | |
| DE69431092T2 (de) | Medizinischer Zement, Verfahren zu seiner Herstellung sowie dessen Verwendung | |
| DE3409372A1 (de) | Material zum vitalisieren von implantatoberflaechen | |
| DE3220932C2 (enrdf_load_stackoverflow) | ||
| DE19813614A1 (de) | Bio-Zemente mit verbesserten Eigenschaften | |
| DE69914264T2 (de) | Knochenregenerierungsmaterial | |
| DE102004016883A1 (de) | Verfahren zur Herstellung eines Knochen-Implantat-materials mit verbesserter mechanischer Beanspruchbarkeit auf der Basis von Formkörpern aus porösem Implantatmaterial sowie nach dem Verfahren hergestelltes Implantatmaterial |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8101 | Request for examination as to novelty | ||
| 8105 | Search report available | ||
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |